Absolute Count of CD19+ B Cells in Peripheral Blood
This test measures the number of a specific type of white blood cell (B cells) that play a key role in the immune system. It helps assess immune function, especially in conditions affecting B cells.
["This test helps evaluate immune health and diagnose or monitor certain blood disorders."]
Key facts at a glance
- LOINC
- 40885-6
- Short code
- CD19CD103
- Synonyms
- CD19+CD103+ Cells NFr Bld
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA (lavender/purple-top) tube, ACD (yellow-top) tube, or sodium heparin (green-top) tube validated for flow cytometry
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Flow cytometry using fluorescently labeled monoclonal antibodies against CD19 and CD103 surface markers, with subsequent cell population gating and enumeration
- CPT
- 86356
- SNOMED
- 11944002
- Specimen volume
- 3-5 mL of whole blood; minimum 1 mL for pediatric samples
- Stability
- Process within 24-48 hours of collection when stored at room temperature (20-25°C). Do not refrigerate or freeze whole blood samples as this may affect cell viability and marker expression.
- Hemolysis max
- 50
- Lipemia max
- 100
- Icterus max
- 20
- TAT
- 4–48 hours
- Order
- routine
Why This Test Is Done
Doctors may order this test if you have symptoms or conditions that suggest an immune system issue, such as frequent infections, autoimmune diseases, or certain cancers (e.g., lymphoma). It may also be used before or after treatments like chemotherapy or immunotherapy that affect B cells.
What to Expect Before the Test
No special preparation is needed. You’ll have a small needle inserted into a vein (usually in your arm) to draw a small amount of blood. The process takes a few minutes and is generally comfortable.
How the Test Results Are Used
Results help determine if your immune system has enough healthy B cells to function properly. Abnormal counts may indicate conditions like immune deficiencies, infections, or certain cancers.
Common Conditions Monitored
This test is often used to monitor B cell-related disorders, including chronic infections, autoimmune diseases (like lupus or rheumatoid arthritis), or before/after treatments for blood cancers or immune disorders.
Reference range
Reference ranges vary by laboratory; typically expressed as percentage of total lymphocytes or absolute count (cells/μL). CD19+CD103+ cells are normally present at very low frequencies in peripheral blood of healthy individuals.N/A
No special preparation required. Patient should be well-hydrated. Recent blood transfusions, immunosuppressive therapy, or chemotherapy may affect results and should be documented.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical significance: Abnormally low or high CD19+ B cell counts can signal underlying immune dysfunction, infection, or malignancy. Doctors will interpret results in the context of your symptoms, medical history, and other tests.
Short name
CD19+ B Cell Count
Frequently asked questions
What does a low CD19+ B cell count mean?
What does a high CD19+ B cell count mean?
How often should I get this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy